BAUSCH + LOMB CORP. Share Price Today: Live Updates & Key Insights

BAUSCH + LOMB CORP. share price today is $16.17, up 1.19%. The stock opened at $16.15 against the previous close of $15.98, with an intraday high of $16.29 and low of $16.

BAUSCH + LOMB CORP. Share Price Chart

BAUSCH + LOMB CORP.

us-stock
To Invest in {{usstockname}}
us-stock

BAUSCH + LOMB CORP. Share Price Performance

$16.17 0.0119(1.19%) BLCO at 27 Jul 2026 02:13 PM Medical Instruments & Supplies
Lowest Today 16
Highest Today 16.29
Today’s Open 16.15
Prev. Close 15.98
52 Week High 18.92
52 Week Low 13.09
Day’s Range: Low 16 High 16.29
52-Week Range: Low 13.09 High 18.92
1 day return -
1 Week return +1.25
1 month return -0.91
3 month return +2.08
6 month return -4.4
1 year return +11.97
3 year return -17.28
5 year return -
10 year return -

BAUSCH + LOMB CORP. Institutional Holdings

Deutsche Bank AG 0.99

ICAHN CARL C 0.98

Oaktree Capital Management LLC 0.95

D. E. Shaw & Co LP 0.88

Goldentree Asset Management LP 0.75

Silver Point Capital LP 0.63

Davidson Kempner Capital Management LP 0.62

Caspian Capital Partners, L.P. 0.56

Glenview Capital Management LLC 0.54

Nomura Holdings Inc 0.35

T. Rowe Price Associates, Inc. 0.34

Whitebox Advisors, LLC 0.31

Arrowstreet Capital Limited Partnership 0.28

Morgan Stanley - Brokerage Accounts 0.24

Clark Estates Inc 0.23

T. Rowe Price High Yield 0.23

T. Rowe Price High Yield Bond 0.23

Citadel Advisors Llc 0.20

Clearline Capital LP 0.20

GordonMD Global Investments LP 0.16

UBS Group AG 0.13

Woodline Partners LP 0.11

Bestinver Norteamérica FI 0.07

T. Rowe Price Instl High Yield 0.06

T. Rowe Price Dynamic Credit I 0.06

Ballast Small/Mid Cap ETF 0.04

Ballast SMidCap 0.04

Gabelli Health & Wellness 0.04

T. Rowe Price Glbl HY Opps Bd C Inc Q 9 0.03

Gabelli Dividend & Income 0.03

Bestinver Megatendencias FI 0.02

Fidelity Tactical High Income Sr F8 0.02

Pleiades Small Cap Equity A 0.02

T. Rowe Price Glb High Inc Bd I 0.02

T. Rowe Price Global High Inc Full Auth 0.02

T. Rowe Price Global High Income Bd 0.02

T. Rowe Price Credit Opportunities 0.01

T. Rowe Price Credit Opportunities Comp 0.01

T. Rowe Price Global Hi Yld Bd A 0.01

Gabelli Asset AAA 0.01

BAUSCH + LOMB CORP. Market Status

Strong Buy: 3

Buy: 3

Hold: 8

Sell: 1

Strong Sell: 0

BAUSCH + LOMB CORP. Fundamentals

Market Cap 5697.45 M

PB Ratio 0.8932

PE Ratio 0.0

Enterprise Value 10491.64 M

Total Assets 14022.00 M

Volume 563840

BAUSCH + LOMB CORP. Company Financials

Annual Revenue FY25:5101000000 5101.0M, FY24:4774000000 4774.0M, FY23:3969000000 3969.0M, FY22:3768000000 3768.0M, FY21:3765000000 3765.0M

Annual Profit FY25:2995000000 2995.0M, FY24:2902000000 2902.0M, FY23:2368000000 2368.0M, FY22:2249000000 2249.0M, FY21:2298000000 2298.0M

Annual Net worth FY25:-360000000 -360.0M, FY24:-317000000 -317.0M, FY23:-207000000 -207.0M, FY22:15000000 15.0M, FY21:182000000 182.0M

Quarterly Revenue Q1/2026:1244000000 1244.0M, Q4/2025:1405000000 1405.0M, Q3/2025:1281000000 1281.0M, Q2/2025:1278000000 1278.0M, Q1/2025:1137000000 1137.0M

Quarterly Profit Q1/2026:704000000 704.0M, Q4/2025:816000000 816.0M, Q3/2025:771000000 771.0M, Q2/2025:753000000 753.0M, Q1/2025:655000000 655.0M

Quarterly Net worth Q1/2026:-71000000 -71.0M, Q4/2025:-58000000 -58.0M, Q3/2025:-28000000 -28.0M, Q2/2025:-62000000 -62.0M, Q1/2025:-212000000 -212.0M

About BAUSCH + LOMB CORP. & investment objective

Company Information Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Organisation Medical Instruments & Supplies

Employees 13000

Industry Medical Instruments & Supplies

CEO Mr. Brenton L. Saunders J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BAUSCH + LOMB CORP. FAQs

What is the share price of BAUSCH + LOMB CORP. today?

The current share price of BAUSCH + LOMB CORP. is $16.17.

Can I buy BAUSCH + LOMB CORP. shares in India?

Yes, Indian investors can buy BAUSCH + LOMB CORP. shares by opening an international trading and demat account with Motilal Oswal.

How to buy BAUSCH + LOMB CORP. shares in India?

You can easily invest in BAUSCH + LOMB CORP. shares from India by:

Can I buy fractional shares of BAUSCH + LOMB CORP.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BAUSCH + LOMB CORP.?

BAUSCH + LOMB CORP. has a market cap of $5697.45 M.

In which sector does BAUSCH + LOMB CORP. belong?

BAUSCH + LOMB CORP. operates in the Medical Instruments & Supplies sector.

What documents are required to invest in BAUSCH + LOMB CORP. stocks?

To invest, you typically need:

What is the PE and PB ratio of BAUSCH + LOMB CORP.?

The PE ratio of BAUSCH + LOMB CORP. is N/A and the PB ratio is 0.89.